Search Results

There are 23743 results for: content related to: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

  1. Update of PET and PET/CT for hepatobiliary and pancreatic malignancies


    Volume 7, Issue 3, September 2005, Pages: 166–179, DOMINIQUE DELBEKE and WILLIAM H. MARTIN

    Version of Record online : 5 NOV 2010, DOI: 10.1080/13651820510028909

  2. You have free access to this content
    The clinical advances of fluorine-2-D-deoxyglucose – positron emission tomography/computed tomography in urological cancers

    International Journal of Urology

    Volume 17, Issue 6, June 2010, Pages: 501–511, Norbert Avril, Fatima Dambha, Iain Murray, Jonathan Shamash, Tom Powles and Anju Sahdev

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1442-2042.2010.02509.x

  3. Factors Influencing [F-18] 2-Fluoro-2-Deoxy-d-Glucose (F-18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity

    The Journal of Dermatology

    Volume 32, Issue 5, May 2005, Pages: 316–334, Kiyoshi Yamada, Ingo Brink, Emmanuel Bissé, Thomas Epting and Rupert Engelhardt

    Version of Record online : 22 JUL 2014, DOI: 10.1111/j.1346-8138.2005.tb00903.x

  4. 2-Deoxy-2-Fluoro-d-Glucose as a Functional Probe for NMR: The Unique Metabolism Beyond Its 6-Phosphate

    Journal of Neurochemistry

    Volume 66, Issue 5, May 1996, Pages: 2113–2120, Y. Kanazawa, H. Yamane, S. Shinohara, S. Kuribayashi, Y. Momozono, Y. Yamato, M. Kojima and K. Masuda

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1996.66052113.x

  5. You have free access to this content
    The role of 18F-fluorodeoxyglucose–positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 866–875, Kwang-Hoon Lee, Arthur Cho, Yun-Jung Choi, Sang-Won Lee, You-Jung Ha, Se-Jin Jung, Min-Chan Park, Jong-Doo Lee, Soo-Kon Lee and Yong-Beom Park

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.33413

  6. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat

    NMR in Biomedicine

    Volume 16, Issue 8, December 2003, Pages: 494–502, Richard Southworth, Craig R. Parry, Harold G. Parkes, Rodolfo A. Medina and Pamela B. Garlick

    Version of Record online : 22 DEC 2003, DOI: 10.1002/nbm.856

  7. PET/CT today and tomorrow in veterinary cancer diagnosis and monitoring: fundamentals, early results and future perspectives

    Veterinary and Comparative Oncology

    Volume 8, Issue 3, September 2010, Pages: 163–187, J. Lawrence, E. Rohren and J. Provenzale

    Version of Record online : 11 MAY 2010, DOI: 10.1111/j.1476-5829.2010.00218.x

  8. PET imaging for pediatric oncology: An assessment of the evidence

    Pediatric Blood & Cancer

    Volume 55, Issue 6, 1 December 2010, Pages: 1048–1061, Carol Portwine, Christopher Marriott and Ronald D. Barr

    Version of Record online : 26 OCT 2010, DOI: 10.1002/pbc.22747

  9. Positron emission tomography application for gynecologic tumors

    International Journal of Gynecological Cancer

    Volume 15, Issue 5, September 2005, Pages: 701–709, Y. NAKAMOTO, T. SAGA and S. FUJII

    Version of Record online : 12 SEP 2005, DOI: 10.1111/j.1525-1438.2005.00245.x

  10. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer

    International Journal of Gynecological Cancer

    Volume 17, Issue 4, July/August 2007, Pages: 890–896, R. SUZUKI, E. MIYAGI, N. TAKAHASHI, A. SUKEGAWA, A. SUZUKI, I. KOIKE, K. SUGIURA, N. OKAMOTO, T. INOUE and F. HIRAHARA

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1525-1438.2007.00859.x

  11. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging

    NMR in Biomedicine

    Volume 10, Issue 1, January 1997, Pages: 35–41, Yoko Kanazawa, Keiko Umayahara, Toshiyuki Shimmura and Tsuneo Yamashita

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1492(199701)10:1<35::AID-NBM447>3.0.CO;2-F

  12. You have free access to this content
    Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma

    BJU International

    Volume 106, Issue 5, September 2010, Pages: 658–663, Michele Lodde, Louis Lacombe, Juan Friede, Francis Morin, Alexandre Saourine and Yves Fradet

    Version of Record online : 13 AUG 2010, DOI: 10.1111/j.1464-410X.2010.09212.x

  13. Molecular imaging of adrenal neoplasms

    Journal of Surgical Oncology

    Volume 106, Issue 5, 1 October 2012, Pages: 532–542, Clara C. Chen and Jorge A. Carrasquillo

    Version of Record online : 24 MAY 2012, DOI: 10.1002/jso.23162

  14. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis

    International Journal of Rheumatic Diseases

    Volume 18, Issue 7, September 2015, Pages: 714–724, Abhijeet Danve and James O'Dell

    Version of Record online : 14 JUL 2015, DOI: 10.1111/1756-185X.12713

  15. Clinical applications of positron emission tomography in hepatic tumors

    Hepatology Research

    Volume 41, Issue 7, July 2011, Pages: 611–617, Susumu Shiomi and Joji Kawabe

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1872-034X.2011.00819.x

  16. Factors Influencing [F-18] 2-Fluoro-2-Deoxy-d-Glucose (F-18 FDG) Accumulation in Melanoma Cells: Is FDG a Substrate of Multidrug Resistance (MDR)?

    The Journal of Dermatology

    Volume 32, Issue 5, May 2005, Pages: 335–345, Kiyoshi Yamada, Ingo Brink and Rupert Engelhardt

    Version of Record online : 22 JUL 2014, DOI: 10.1111/j.1346-8138.2005.tb00904.x

  17. You have free access to this content
    Vascular imaging with positron emission tomography

    Journal of Internal Medicine

    Volume 270, Issue 2, August 2011, Pages: 99–109, F. Joshi, D. Rosenbaum, S. Bordes and J. H. F. Rudd

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1365-2796.2011.02392.x

  18. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study

    Diseases of the Esophagus

    Volume 25, Issue 5, July 2012, Pages: 416–426, D. Han, J. Yu, X. Zhong, Z. Fu, D. Mu, B. Zhang, G. Xu, W. Yang and S. Zhao

    Version of Record online : 23 SEP 2011, DOI: 10.1111/j.1442-2050.2011.01259.x

  19. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET

    Magnetic Resonance in Medicine

    Volume 69, Issue 3, 1 March 2013, Pages: 781–792, Eric Poulin, Réjean Lebel, Etienne Croteau, Marie Blanchette, Luc Tremblay, Roger Lecomte, M'hamed Bentourkia and Martin Lepage

    Version of Record online : 8 MAY 2012, DOI: 10.1002/mrm.24318

  20. You have full text access to this OnlineOpen article
    The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 7–15, Sarah J. Nagle, Elise A. Chong, Seble Chekol, Nirav N. Shah, Sunita D. Nasta, Eli Glatstein, John P. Plastaras, Drew A. Torigian, Stephen J. Schuster and Jakub Svoboda

    Version of Record online : 10 SEP 2014, DOI: 10.1002/cam4.322